The firm has settled on a set of metabolite biomarkers, along with an algorithm, for its first version of a test for arterial plaque buildup.
The firm will adapt multiplex panels for prognosis of septic shock patients to its array-based portable diagnostic platform.
The new platform, called Fusion, is an addition to the Panther system and will run qPCR assays with three "mini panels" currently in the works.
The companies will use their respective technologies to develop multiplex molecular diagnostic panels for laboratory testing.
The firm priced each share at $.47, and plans to use the funding for general corporate purposes and working capital.
The scientists believe they have created a more accurate way to detect mutations that often lead to hereditary colorectal cancer.
The San Diego diagnostics firm's technology is designed for rapid, multiplexed, blood-based testing in a physician's office setting.
The special conditions of MDx use in the pediatric market may also present advantages in patient satisfaction metrics, a BioFire representative said.
The researchers are also developing the method in tandem with a more extensive pathogen profiling diagnostic platform from Swedish startup Q-linea.
NEW YORK (GenomeWeb News) – MRC Technology today announced a collaboration with Renishaw Diagnostics to identify and develop clinical diagnostic tests for infectious diseases.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.